Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.


NIH GUIDE, Volume 23, Number 24, June 24, 1994


P.T. 34




  Chemistry, Organic 

  Chemical Synthesis 

National Institute of Child Health and Human Development

The Contraceptive Development Branch of the Center for Population

Research, National Institute of Child Health and Human Development, is

interested in stimulating investigations into the synthesis, testing,

and development of novel spermicidal\anti-STD agents that inactivate

human sperm and sexually transmitted disease (STD) pathogens,

especially HIV, preferably via mechanisms other than the disruption of

cell membranes.  The spermicidal\anti-STD agent is defined as (1) an

agent comprised of a single chemical entity possessing both spermicidal

and anti-STD activity or (2) an agent that is comprised of two chemical

entities, one possessing spermicidal activity and the other anti-STD

activity.  The goals are to obtain human spermicidal\anti-STD agents

that (a) are equipotent with or more potent than nonoxynol-9 (N-9), (b)

have a rapid onset of sperm inactivation equivalent to or greater than

that of N-9, (c) do not cause vaginal irritation, (d) can inactivate

STD pathogens while producing only a transient effect on normal human

vaginal flora, (e) are miscible with human cervical mucus, (f) are

inexpensive, and (g) are aesthetically pleasing (i.e., colorless,

odorless).  Such investigations will involve the synthesis and

biological evaluation of the spermicidal\anti-STD agents by the


This project requires both the expertise of a Ph.D. synthetic organic

or medicinal chemist and a Ph.D. biologist.  A collaborative effort

(in-house or via subcontract arrangement) of such scientists is

essential for the success of the project.  Organizations must have

adequate facilities to carry out the proposed syntheses and biological

testing.  The Government estimates the effort to be approximately 4.0

technical person-years annually.  The principal investigator or

co-principal investigators should devote approximately 20 percent

effort to this project.

All responsible sources may submit a proposal that will be considered

by the agency.  It is anticipated that five cost-reimbursement

incrementally funded type contracts will be awarded as a result of the

Request for Proposals (RFP) for a period of 36 months, beginning April

3, 1995.  This announcement is not an RFP.  RFP No. NICHD-CD-94-14 will

be available on or about June 30, 1994.  Proposals will be due

approximately 90 days thereafter.


Requests for the RFP must cite the above RFP number.  Copies of the RFP

may be obtained by sending a written or FAX request to:

Paul J. Duska

Office of Grants and Contracts

National Institute of Child Health and Human Development

6100 Building, Suite 7A-07

Bethesda, MD  20892

FAX:  (301) 402-3676


Return to 1994 Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.